2022 American Transplant Congress

TOPIC: Clinical Science » Kidney » 36 - Kidney Immunosuppression: Desensitization

Pre-Transplant Desensitization Utilizing Intravenous Immune-Globulin and Tocilizumab: A Single Center Experience
I. Moinuddin, M. Miles, S. Sterling, A. Brown, P. Kimball, G. Gupta
Temporary Donor Splenic Transplant (Splenopheresis) in Simultaneous Kidney Transplant Provides a Safe Immunologic Window in Sensitized Patients
P. Di Cocco¹, S. Gaitonde², M. Spaggiari³, A. M. Fratti³, S. Akshelyan³, A. Jorge¹, E. Benedetti³, I. Tzvetanov³
Two Times or More Double-Filtration Plasmapheresis Increases the Risk of Bleeding During Kidney Transplantation
T. Kanzawa, T. Tagisawa, M. Furusawa, K. Unagami, K. Kitajima, K. Omoto, H. Ishida, K. Tanabe, T. Takagi
Validation of Donor Specific Antibody Characteristics Associated with Deleterious Outcomes: A Single Center Study of 940 Kidney Allograft Recipients
P. Lamba¹, I. Lamba¹, R. Friedlander², V. Sharma³, J. Lee², J. B. Lee⁴, C. Hartono⁵, M. Thangamani⁶, D. Sawinski², T. Salinas⁷, M. Suthanthiran⁸, D. Dadhania⁹